DK0807185T3 - Antitumorpræparater indeholdende en lipoteichoinsyre fra streptococcus - Google Patents
Antitumorpræparater indeholdende en lipoteichoinsyre fra streptococcusInfo
- Publication number
- DK0807185T3 DK0807185T3 DK96902922T DK96902922T DK0807185T3 DK 0807185 T3 DK0807185 T3 DK 0807185T3 DK 96902922 T DK96902922 T DK 96902922T DK 96902922 T DK96902922 T DK 96902922T DK 0807185 T3 DK0807185 T3 DK 0807185T3
- Authority
- DK
- Denmark
- Prior art keywords
- new
- lta
- streptococcus
- lipoteichoic acid
- grop
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/885—Streptococcus
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95101208 | 1995-01-30 | ||
PCT/EP1996/000309 WO1996023896A1 (en) | 1995-01-30 | 1996-01-24 | Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0807185T3 true DK0807185T3 (da) | 2002-10-07 |
Family
ID=8218940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96902922T DK0807185T3 (da) | 1995-01-30 | 1996-01-24 | Antitumorpræparater indeholdende en lipoteichoinsyre fra streptococcus |
Country Status (11)
Country | Link |
---|---|
US (2) | US6114161A (da) |
EP (1) | EP0807185B9 (da) |
JP (1) | JP3638955B2 (da) |
CN (1) | CN1113102C (da) |
AT (1) | ATE219146T1 (da) |
AU (1) | AU4714196A (da) |
CA (1) | CA2208780C (da) |
DE (1) | DE69621776T2 (da) |
DK (1) | DK0807185T3 (da) |
ES (1) | ES2178699T3 (da) |
WO (1) | WO1996023896A1 (da) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3638955B2 (ja) * | 1995-01-30 | 2005-04-13 | トルオク,ペーター | 連鎖球菌属からのリポテイコ酸を含有する抗腫瘍及び抗コレステロール製剤 |
US6610293B1 (en) | 1997-06-16 | 2003-08-26 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine | Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
DE19728900A1 (de) * | 1997-07-07 | 1999-01-14 | Henkel Kgaa | Hydrophile Glykoside |
EP1832662B1 (en) * | 1998-04-02 | 2011-03-09 | The Board Of Regents Of The University Of Oklahoma | DNA encoding chondroitin synthase from Pasteurella multocida and methods of use |
EP1425390B1 (en) | 2001-08-13 | 2012-02-01 | University of Florida Research Foundation, Inc. | Materials and methods to promote repair of nerve tissue |
EP1521523A4 (en) * | 2002-05-20 | 2006-04-19 | Univ Texas | METHODS AND COMPOSITIONS FOR DELIVERING NUCLEIC ACID ENZYMES AND MOLECULES IN BRAIN, BONE, AND OTHER FABRICS |
KR100443080B1 (ko) * | 2002-07-11 | 2004-08-04 | 일동제약주식회사 | 콜레스테롤 저하능을 갖는 스트렙토코커스 페시움 균주 |
JP2006514636A (ja) * | 2002-12-02 | 2006-05-11 | バイオシネクサス インコーポレーテッド | 抗ブドウ球菌療法およびワクチンの標的としての壁テイコイン酸 |
GB0717442D0 (en) * | 2007-09-07 | 2007-10-17 | Isis Innovation | Compositions and uses thereof |
SG10201704269RA (en) | 2009-07-15 | 2017-06-29 | Aimm Therapeutics Bv | Gram-positive bacteria specific binding compounds |
JP2013502456A (ja) * | 2009-08-26 | 2013-01-24 | アールエヌエー アイエヌシー | リポタイコ酸由来の糖脂質及びこれを含む組成物 |
EP2380565A1 (en) | 2010-03-31 | 2011-10-26 | Lunamed AG | Compositions for dental treatment comprising Lipoteichoic acids or parts thereof like mono- or polyglycerphosphates |
ES2544808T3 (es) * | 2011-03-11 | 2015-09-04 | Universitätsklinikum Freiburg | Miméticos sintéticos de LTA y uso de los mismos como componente de vacuna para la terapia y/o profilaxis de infecciones gram-positivas |
EP2545911A1 (en) | 2011-07-12 | 2013-01-16 | Lunamed AG | Use of Lipoteichoic Acid in the Treatment of Non-Encapsulated Cancer Cells |
EP2545909A1 (en) | 2011-07-12 | 2013-01-16 | Lunamed AG | Combination of D-Amino Acids and Lipoteichoic Acid |
EP2545910A1 (en) | 2011-07-12 | 2013-01-16 | Lunamed AG | Use of Lipoteichoic Acid in the treatment of cancer in an inflammatory state |
EP2574237A1 (en) | 2011-09-30 | 2013-04-03 | Lunamed AG | Use of a lipoteichoic acid, mono- or polyglycerophosphate for antibacterial pre-treatment and especially in medical devices |
EP2589387A1 (en) | 2011-11-04 | 2013-05-08 | Lunamed AG | Use of a teichoic acid for the treatment of malignant liquor cerebrospinalis in the brain |
EP2589388A1 (en) | 2011-11-04 | 2013-05-08 | Lunamed AG | Use of a Teichoic acid for the treatment of malignant ascites |
KR102259799B1 (ko) * | 2018-06-01 | 2021-06-02 | 경희대학교 산학협력단 | 리포테이코익산, TNF-α 및 IFN-γ를 유효성분으로 함유하는 항암용 조성물 |
KR20190137397A (ko) * | 2018-06-01 | 2019-12-11 | 경희대학교 산학협력단 | 리포테이코익산, TNF-α 및 IFN-γ를 유효성분으로 함유하는 항암용 조성물 |
CN115279380A (zh) | 2019-12-27 | 2022-11-01 | 佰欧波利斯有限公司 | 来自双歧杆菌的脂磷壁酸的用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3729461A (en) * | 1970-12-23 | 1973-04-24 | Us Agriculture | Synthesis of glycosyl glycerides |
SU787414A1 (ru) * | 1978-10-05 | 1980-12-15 | Московский Ордена Трудового Красного Знамени Институт Тонкой Химической Технологии Им. М.В. Ломоносова | Способ получени 1,2-ди-0-пальмитоил- 3-0-/6-0-(1,2-ди-0-пальмитоил- - глицеро-3-0-фосфорил)- - глюкопиранозил/- -глицерина |
US4678773A (en) * | 1983-08-26 | 1987-07-07 | Chugai Seiyaku Kabushiki Kaisha | Antitumor agent |
JPS61275217A (ja) * | 1985-05-29 | 1986-12-05 | Yakult Honsha Co Ltd | グラム陰性桿菌感染症防御剤 |
JPS6456692A (en) * | 1987-08-27 | 1989-03-03 | Nisshin Oil Mills Ltd | Production of sugar glycerol |
JPS6467237A (en) * | 1987-09-09 | 1989-03-13 | Nisshin Oil Mills Ltd | Novel surface active composition and emulsified composition combined therewith |
NL9100510A (nl) * | 1991-03-21 | 1992-10-16 | Centraal Diergeneeskundig Inst | Dna-sequenties die coderen voor kenmerken van virulentie van streptococcus suis en delen daarvan, daarvan afgeleide polypeptiden en antilichamen, alsmede toepassing daarvan bij de diagnose van en de bescherming tegen infectie met s. suis bij zoogdieren, waaronder de mens. |
AU6362594A (en) * | 1993-03-10 | 1994-09-26 | Miles Inc. | Hyaluronic acid used as a cancer treatment |
JP3638955B2 (ja) * | 1995-01-30 | 2005-04-13 | トルオク,ペーター | 連鎖球菌属からのリポテイコ酸を含有する抗腫瘍及び抗コレステロール製剤 |
-
1996
- 1996-01-24 JP JP52322796A patent/JP3638955B2/ja not_active Expired - Fee Related
- 1996-01-24 DE DE69621776T patent/DE69621776T2/de not_active Expired - Lifetime
- 1996-01-24 CN CN96191668A patent/CN1113102C/zh not_active Expired - Fee Related
- 1996-01-24 DK DK96902922T patent/DK0807185T3/da active
- 1996-01-24 AT AT96902922T patent/ATE219146T1/de active
- 1996-01-24 WO PCT/EP1996/000309 patent/WO1996023896A1/en active IP Right Grant
- 1996-01-24 ES ES96902922T patent/ES2178699T3/es not_active Expired - Lifetime
- 1996-01-24 EP EP96902922A patent/EP0807185B9/en not_active Expired - Lifetime
- 1996-01-24 CA CA2208780A patent/CA2208780C/en not_active Expired - Fee Related
- 1996-01-24 US US08/875,018 patent/US6114161A/en not_active Expired - Lifetime
- 1996-01-24 AU AU47141/96A patent/AU4714196A/en not_active Abandoned
-
1999
- 1999-01-15 US US09/232,106 patent/US6214978B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2178699T3 (es) | 2003-01-01 |
JP3638955B2 (ja) | 2005-04-13 |
DE69621776T2 (de) | 2003-01-30 |
AU4714196A (en) | 1996-08-21 |
CA2208780A1 (en) | 1996-08-08 |
JPH11500901A (ja) | 1999-01-26 |
US6114161A (en) | 2000-09-05 |
EP0807185A1 (en) | 1997-11-19 |
CN1113102C (zh) | 2003-07-02 |
DE69621776D1 (de) | 2002-07-18 |
ATE219146T1 (de) | 2002-06-15 |
US6214978B1 (en) | 2001-04-10 |
CA2208780C (en) | 2010-03-30 |
EP0807185B1 (en) | 2002-06-12 |
WO1996023896A1 (en) | 1996-08-08 |
CN1173206A (zh) | 1998-02-11 |
EP0807185B9 (en) | 2002-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0807185T3 (da) | Antitumorpræparater indeholdende en lipoteichoinsyre fra streptococcus | |
ZA894380B (en) | Essential fatty acid compositions | |
BG102312A (en) | New derivatives of 5-oxy-deoaminyl 6-oxy-methyl erythronolide a, method for their preparation and application for the preparation of biologically active products | |
CY1112927T1 (el) | Αντισωματα κατα της ανθρωπινης il-12 | |
ATE66350T1 (de) | Suessware und verfahren zur herstellung derselben. | |
ES551563A0 (es) | Procedimiento para la preparacion de un suplemento mineral masticable | |
IL69930A (en) | Oral mopidamol preparations and their production | |
IL107255A0 (en) | Chewable pharmaceutical compositions | |
GR3037011T3 (en) | Vaccine composition containing polyribosylribitol phosphate and method for making same | |
EP0312086A3 (de) | Polyschwefelsäureester von Bis-aldonsäureamiden und deren Derivaten, Verfahren zu ihrer Herstellung und Arzneimittel | |
DE3479189D1 (en) | Pharmaceutical composition with special 1,2-diacyl-glycero-3-phosphocholines for the treatment of diseases of the stomach and the intestines | |
JPS5782322A (en) | Novel immunostimulant sugar protein extracted from pneumonia bacillus,obtaining method, application as drug and composition containing same | |
ES2009248A6 (es) | Composicion dietetica a base de algas que contengan selenio. | |
HUT52476A (en) | Process for producing side chain unsaturated 1 alpha-hydroxy-d-vitamin homologues and pharmaceutical compositions comprising such compounds | |
FR2658516B1 (fr) | Nouveaux produits sterouides comportant un radical spiro en position 17, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant. | |
ATE135917T1 (de) | Stabilisierte pharmaceutische zusammensetzung die nicht-glycozylierte, reduzierte rekombinante human il-2 umfasst und verfahren zu ihrer herstellung | |
ATE160788T1 (de) | Dextranester, verfahren zu ihrer herstellung und ihre verwendung zur umhüllung oder einbettung von arzneimitteln | |
AU4294496A (en) | Methods for the preparation of pure homologous series of mono to tetra fatty acyl esters of sugars; characterization of one antitumor component as maltose 1, 6, 6' tripalmitate: and pharmaceutical formulations useful in the treatment of cancer. | |
Boquet et al. | Fragment beta of tetanus toxin forms channels in lipid vesicles at low pH. | |
MX9705082A (es) | Composiciones para el suministro de antigenos. | |
GEP19981197B (en) | Emulsion for Treatment of Ulcer Diseases |